Abstract
Rationale
Neurobiological models of addiction suggest that abnormalities of brain reward circuitry distort salience attribution and inhibitory control processes, which in turn contribute to high relapse rates.
Objectives
The aim of this study is to determine whether impairments of salience attribution and inhibitory control predict relapse in a pharmacologically unaided attempt at smoking cessation.
Methods
One hundred forty one smokers were assessed on indices of nicotine consumption/dependence (e.g. The Fagerström Test of Nicotine Dependence, cigarettes per day, salivary cotinine) and three trait impulsivity measures. After overnight abstinence, they completed experimental tests of cue reactivity, attentional bias to smoking cues, response to financial reward, motor impulsiveness and response inhibition (antisaccades). They then started a quit attempt with follow-up after 7 days, 1 month and 3 months; abstinence was verified via salivary cotinine levels ≤20 ng/ml.
Results
Relapse rates at each point were 52.5%, 64% and 76.3%. The strongest predictor was pre-cessation salivary cotinine; other smoking/dependence indices did not explain additional outcome variance and neither did trait impulsivity. All experimental indices except responsivity to financial reward significantly predicted a 1-week outcome. Salivary cotinine, attentional bias to smoking cues and antisaccade errors explained unique as well as shared variance. At 1 and 3 months, salivary cotinine, motor impulsiveness and cue reactivity were all individually predictive; the effects of salivary cotinine and motor impulsiveness were additive.
Conclusions
These data provide some support for the involvement of abnormal cognitive and motivational processes in sustaining smoking dependence and suggest that they might be a focus of interventions, especially in the early stages of cessation.
Similar content being viewed by others
References
Abrams DB, Follick MJ, Biener L, Carey KB, Hitti J (1987) Saliva cotinine as a measure of smoking status in field settings. Am J Public Health 77:846–848
Adinoff B (2004) Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry 12:305–320
al’Absi M, Hatsukami D, Davis GL, Wittmers LE (2004) Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse. Drug Alcohol Depend 8:267–278
Al-Adawi S, Powell JH (1997) The influence of smoking on reward responsiveness and cognitive functions: a natural experiment. Addiction 92:1757–1766
Alsene KM, Mahler SV, de Wit H (2005) Effects of d-amphetamine and smoking abstinence on cue-induced cigarette craving. Exp Clin Psychopharmacol 13:209–218
Altmann J, Everitt BJ, Glautier S, Markou A, Nutt D, Oretti R, Phillips GD, Robbins TW (1996) The biological, social and clinical bases of drug addiction: commentary and debate. Psychopharmacol 125:285–345
Bickel WK, Odum AL, Madden GJ (1999) Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacol 146:447–454
Breslau N, Johnson EO (2000) Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health 90:1122–1127
Cahill K, Perera R (2008) Competitions and incentives for smoking cessation. Cochrane Database Syst Rev 16:CD004307
Carter BL, Tiffany ST (1999) Meta-analysis of cue-reactivity in addiction research. Addiction 94:327–340
Chikazoe J, Konishi S, Asari T, Jimura K, Miyashita Y (2007) Activation of right inferior frontal gyrus during response inhibition across response modalities. J Cogn Neurosci 19:69–80
Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science 236:410–416
Cook JW, Spring B, McChargue D (2007) Influence of nicotine on positive affect in anhedonic smokers. Psychopharmacol 192:87–95
Dawe S, Gullo MJ, Loxton NJ (2004) Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse. Addict Behav 29:1389–1405
Dawkins L, Powell JH, West R, Powell JF, Pickering A (2006) A double-blind placebo controlled experimental study of nicotine: I—effects on incentive motivation. Psychopharmacol 189:355–368
Dawkins L, Powell JH, West R, Powell JF, Pickering A (2007a) A double-blind placebo controlled experimental study of nicotine: II—effects on response inhibition and executive functioning. Psychopharmacol 190:457–467
Dawkins L, Acaster S, Powell JH (2007b) The effects of smoking and abstinence on experience of happiness and sadness in response to positively valenced, negatively valenced and neutral film clips. Addict Behav 32:425–431
Dawkins L, Powell JH, Pickering A, Powell J, West R (2009) Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence. Addiction 104:850–858
Donny EC, Griffin KM, Shiffman S, Sayette MA (2008) The relationship between cigarette use, nicotine dependence, and craving in laboratory volunteers. Nicotine Tob Res 10:934–942
Doran N, Spring B, McChargue D, Pergadia M, Richmond M (2004) Impulsivity and smoking relapse. Nicotine Tob Res 6:641–647
Dougherty DM, Moeller FG, Steinberg JL, Marsh DM, Hines SE, Bjork JM (1999) Alcohol increases commission error rates for a continuous performance test. Alcohol Clin Exp Res 23:1342–1351
Droungas A, Ehrman RN, Childress AR, O’Brien CP (1995) Effect of smoking cues and cigarette availability on craving and smoking behavior. Addict Behav 20(6):57–73
Etter JF, Vu Duc T, Perneger TV (2000) Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol 151:251–258
Eysenck HJ, Eysenck SBG (1991) Adult IVE. Hodder & Stoughton, London
Field M, Mogg K, Bradley BP (2004) Eye movements to smoking-related cues: effects of nicotine deprivation. Psychopharmacol 173:116–123
Field M, Santarcangelo M, Sumnall H, Goudie A, Cole J (2006) Delay discounting and the behavioural economics of cigarette purchases in smokers: the effects of nicotine deprivation. Psychopharmacol 186:255–263
Fukushima J, Fukushima K, Miyasaka K, Yamashita I (1994) Voluntary control of saccadic eye movement in patients with frontal cortical lesions and Parkinsonian patients in comparison with that in schizophrenics. Biol Psychiatry 36:21–30
Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642–1652
Goudriaan AE, Oosterlaan J, De Beurs E, Van Den Brink W (2008) The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers. Psychol Med 38:41–50
Gurpegui M, Jurado D, Luna JD, Fernández-Molina C, Moreno-Abril O, Gálvez R (2007) Personality traits associated with caffeine intake and smoking. Prog Neuropsychopharm Biol Psychiat 31:997–1005
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 86:1119–1127
Hughes JR, Keely J, Niaura R, Ossip-Klein D, Richmond R, Swan G (2003) Measures of abstinence from tobacco in clinical trials: issues and recommendations. Nicotine Tob Res 5:13–26
Hughes JR, Keely J, Naud S (2004) Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99:29–38
Jentsch JD, Taylor RD (1999) Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacol 146:373–390
Kalamboka N, Remington B, Glautier S (2009) Nicotine withdrawal and reward responsivity in a card-sorting task. Psychopharmacology 204:155–163
Koob GF, Nestler EJ (1997) The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 9:482–497
Krishnan-Sarin S, Reynolds B, Duhig AM, Smith A, Liss T, McFetridge A, Cavallo DA, Carroll KM, Potenza MN (2007) Behavioral impulsivity predicts treatment outcome in a smoking cessation programme for adolescent smokers. Drug Alcohol Depend 88:79–82
Lamb RJ, Morral AR, Kirby KC, Javors MA, Galbicka G, Iguchi M (2007) Contingencies for change in complacent smokers. Exp Clin Psychopharmacol 15:245–255
Lejuez CW, Aklin WM, Jones HA, Richards JB, Strong DR, Kahler CW, Read JP (2003) The Balloon Analogue Risk Task, BART, differentiates smokers and nonsmokers. Exp Clin Psychopharmacol 11:26–33
Leventhal AM, Ramsey SE, Brown RA, LaChance HR, Kahler CW (2008) Dimensions of depressive symptoms and smoking cessation. Nicotine Tob Res 10:507–517
Lingford-Hughes A (2005) Human brain imaging and substance abuse. Curr Opin Pharmacol 5:42–46
Mann K, Günther A, Stetter F, Ackermann K (1999) Rapid recovery from cognitive deficits in abstinent alcoholics: a controlled test-retest study. Alcohol Alcohol 34:567–574
Marissen MA, Franken IH, Waters AJ, Blanken P, van den Brink W, Hendriks VM (2006) Attentional bias predicts heroin relapse following treatment. Addiction 101:1306–1312
McBride D, Barrett SP, Kelly JT, Aw A, Dagher A (2006) Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study. Neuropsychopharmacology 31:2728–2738
McDonald J, Schleifer L, Richards JB, de Wit H (2003) Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28:1356–1365
Meda SA, Stevens MC, Potenza MN, Pittman B, Gueorguieva R, Andrews MM, Thomas AD, Muska C, Hylton JL, Pearlson GD (2009) Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol 20:390–399
Mitchell SH (1999) Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology 146:455–464
Mogg K, Bradley BP (2002) Selective processing of smoking-related cues in smokers: manipulation of deprivation level and comparison of three measures of processing bias. Psychopharmacology 16:385–392
Myung SK, Seo HG, Park S, Kim Y, Kim DJ, Lee do H, Seong MW, Nam MH, Oh SW, Kim JA, Kim MY (2007) Sociodemographic and smoking behavioral predictors associated with smoking cessation according to follow-up periods: a randomized, double-blind, placebo-controlled trial of transdermal nicotine patches. J Korean Med Sci 22:1065–1070
Niaura R, Abrams DB, Shadel WG, Rohsenow DJ, Monti PM, Sirota AD (1999) Cue exposure treatment for smoking relapse prevention: a controlled clinical trial. Addiction 94:685–695
Nigg JT, Butler KM, Huang-Pollock CL, Henderson JM (2002) Inhibitory processes in adults with persistent childhood onset ADHD. J Consult Clin Psychol 70:153–157
Nollen NL, Mayo MS, Sanderson Cox L, Okuyemi KS, Choi WS, Kaur H, Ahluwalia JS (2006) Predictors of quitting among African American light smokers enrolled in a randomized, placebo-controlled trial. J Gen Intern Med 21:590–595
Nørregaard J, Tønnesen P, Petersen L (1993) Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med 22:261–271
Payne TJ, Smith PO, Adams SG, Diefenbach L (2006) Pretreatment cue reactivity predicts end-of-treatment smoking. Addict Behav 31:702–710
Piper ME, McCarthy DE, Bolt DM, Smith SS, Lerman C, Benowitz N, Fiore MC, Baker TB (2008) Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale, NDSS, and the Wisconsin Inventory of Smoking Dependence Motives, WISDM. Nicotine Tob Res 10:1009–1020
Powell JH, Dawkins L, Davis R (2002a) Smoking, desire, and planfulness: tests of an incentive motivational model. Biol Psychiatry 51:151–163
Powell JH, Tait S, Lessiter J (2002b) Cigarette smoking and attention to pleasure and threat words in the Stroop paradigm. Addiction 97:1163–1170
Reynolds B, Richards JB, Horn K, Karraker K (2004) Delay discounting and probability discounting as related to cigarette smoking status in adults. Behav Process 65:35–42
Reynolds B, Ortengren A, Richards JB, de Wit H (2006) Dimensions of impulsive behavior: personality and behavioral measures. Pers Individ Differ 40:305–315
Rose JE, Behm FM, Salley AN, Bates JE, Coleman RE, Hawk TC, Turkington TG (2007) Regional brain activity correlates of nicotine dependence. Neuropsychopharmacology 32:2441–2452
Rubinstein ML, Thompson PJ, Benowitz NL, Shiffman S, Moscicki AB (2007) Cotinine levels in relation to smoking behavior and addiction in young adolescent smokers. Nicotine Tob Res 9:129–135
Shadel WG, Niaura R, Brown RA, Hutchison KE, Abrams DB (2001) A content analysis of smoking craving. J Clin Psychol 57:145–150
Shiffman S, West R, Gilbert D (2004) Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob Res 6:599–614
Spinella M (2002) Correlations between orbitofrontal dysfunction and tobacco smoking. Addict Biol 7:381–384
Velicer WF, Prochaska JO (2004) A comparison of four self-report smoking cessation outcome measures. Addict Behav 29:51–60
Verdejo-Garcia A, Lawrence AJ, Clark L (2008) Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 32:777–810
Volkow ND, Fowler JS, Wang GJ, Swanson JM (2004) Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 9:556–569
Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009) Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56(Suppl 1):3–8
Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH (2003a) Attentional bias predicts outcome in smoking cessation. Health Psychol 22:378–387
Waters AJ, Shiffman S, Bradley BP, Mogg K (2003b) Attentional shifts to smoking cues in smokers. Addiction 98:1409–1417
Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH (2004) Cue-provoked craving and nicotine replacement therapy in smoking cessation. J Consult Clin Psychol 72:1136–1143
Weinstein A, Cox WM (2006) Cognitive processing of drug-related stimuli: the role of memory and attention. J Psychopharmacol 20:850–859
West RJ, Hajek P (2004) Evaluation of the mood and physical symptoms scale, MPSS, to assess cigarette withdrawal. Psychopharmacology 177:195–199
West RJ, Russell MAH (1985) Pre-abstinence nicotine intake and smoking motivation as predictors of cigarette withdrawal symptoms. Psychopharmacology 87:334–336
West R, Ussher M (2010) Is the ten-item Questionnaire of Smoking Urges (QSU-brief) more sensitive to abstinence than shorter craving measures? Psychopharmacol 208:427–432
Yucel M, Lubman DI (2007) Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug Alcohol Depend 26:33–39
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiat Scand 67:361–370
Zuckerman M, Eysenck S, Eysenck HJ (1978) Sensation seeking in England and America: cross-cultural age and sex comparisons. J Consult Clin Psychol 46:139–149
Acknowledgements
This research was funded by the National Institute of Drug Abuse (grant code 3527427). We thank Drs. Kiki Nikolaou, Ian Tharp, Mary Cochrane and Atsuko Inoue for their assistance with the recruitment and testing of participants in this study.
Ethics
This study complies with the current laws and ethical requirements of the UK. It was approved by the Ethics Committee of Goldsmiths, University of London and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding
This research was funded by the National Institute of Drug Abuse (grant code 3527427).
An erratum to this article can be found at http://dx.doi.org/10.1007/s00213-011-2300-x
Rights and permissions
About this article
Cite this article
Powell, J., Dawkins, L., West, R. et al. Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology 212, 537–549 (2010). https://doi.org/10.1007/s00213-010-1975-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-010-1975-8